|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer Clin. 64:9–29. 2014. View Article : Google Scholar
|
|
2
|
Giraldo NA, Becht E, Vano Y,
Sautès-Fridman C and Fridman WH: The immune response in cancer:
From immunology to pathology to immunotherapy. Virchows Arch.
467:127–135. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu Y, Fu X, Zhu X, He X, Zou C, Han Y, Xu
M, Huang C, Lu X and Zhao Y: Prognostic role of systemic
inflammatory response in renal cell carcinoma: A systematic review
and meta-analysis. J Cancer Res Clin Oncol. 137:887–896. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Menter DG, Tucker SC, Kopetz S, Sood AK,
Crissman JD and Honn KV: Platelets and cancer: A casual or causal
relationship: Revisited. Cancer Metastasis Rev. 33:231–269. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yan M and Jurasz P: The role of platelets
in the tumor microenvironment: From solid tumors to leukemia.
Biochim Biophys Acta. 1863:392–400. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Franco AT, Corken A and Ware J: Platelets
at the interface of thrombosis, inflammation, and cancer. Blood.
126:582–588. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Templeton AJ, McNamara MG, Šeruga B,
Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G,
Knox JJ, Tran B, et al: Prognostic role of neutrophil-to-lymphocyte
ratio in solid tumors: A systematic review and meta-analysis. J
Natl Cancer Inst. 106:dju1242014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Paramanathan A, Saxena A and Morris DL: A
systematic review and meta-analysis on the impact of pre-operative
neutrophil lymphocyte ratio on long term outcomes after curative
intent resection of solid tumours. Surg Oncol. 23:31–39. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xin-Ji Z, Yong-Gang L, Xiao-Jun S, Xiao-Wu
C, Dong Z and Da-Jian Z: The prognostic role of neutrophils to
lymphocytes ratio and platelet count in gastric cancer: A
meta-analysis. Int J Surg. 21:84–91. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Templeton AJ, Ace O, McNamara MG,
Al-Mubarak M, Vera-Badillo FE, Hermanns T, Seruga B, Ocaña A,
Tannock IF and Amir E: Prognostic role of platelet to lymphocyte
ratio in solid tumors: A systematic review and meta-analysis.
Cancer Epidemiol Biomarkers Prev. 23:1204–1212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sobin LH, Gospodarowicz MK and Wittekind
CH: Breast tumours. TNM Classification of Malignant Tumours (7th).
Wiley-Blackwell. (Chichester, West Sussex, UK). 181–193. 2010.
|
|
12
|
Ozyalvacli G, Yesil C, Kargi E, Kizildag
B, Kilitci A and Yilmaz F: Diagnostic and prognostic importance of
the neutrophil lymphocyte ratio in breast cancer. Asian Pac J
Cancer Prev. 15:10363–10366. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dirican A, Kucukzeybek BB, Alacacioglu A,
Kucukzeybek Y, Erten C, Varol U, Somali I, Demir L, Bayoglu IV,
Yildiz Y, et al: Do the derived neutrophil to lymphocyte ratio and
the neutrophil to lymphocyte ratio predict prognosis in breast
cancer? Int J Clin Oncol. 20:70–81. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jia W, Wu J, Jia H, Yang Y, Zhang X, Chen
K and Su F: The peripheral blood neutrophil-to-lymphocyte ratio is
superior to the lymphocyte-to-monocyte ratio for predicting the
long-term survival of triple-negative breast cancer patients. PLoS
One. 10:e01430612015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Azab B, Shah N, Radbel J, Tan P, Bhatt V,
Vonfrolio S, Habeshy A, Picon A and Bloom S: Pretreatment
neutrophil/lymphocyte ratio is superior to platelet/lymphocyte
ratio as a predictor of long-term mortality in breast cancer
patients. Med Oncol. 30:4322013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koh CH, Bhoo-Pathy N, Ng KL, Jabir RS, Tan
GH, See MH, Jamaris S and Taib NA: Utility of pre-treatment
neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as
prognostic factors in breast cancer. Br J Cancer. 113:150–158.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Noh H, Eomm M and Han A: Usefulness of
pretreatment neutrophil to lymphocyte ratio in predicting
disease-specific survival in breast cancer patients. J Breast
Cancer. 16:55–59. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yao M, Liu Y, Jin H, Liu X, Lv K, Wei H,
Du C, Wang S, Wei B and Fu P: Prognostic value of preoperative
inflammatory markers in Chinese patients with breast cancer. Onco
Targets Ther. 7:1743–1752. 2014.PubMed/NCBI
|
|
19
|
Koh YW, Lee HJ, Ahn JH, Lee JW and Gong G:
Prognostic significance of the ratio of absolute neutrophil to
lymphocyte counts for breast cancer patients with ER/PR-positivity
and HER2-negativity in neoadjuvant setting. Tumour Biol.
35:9823–9830. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ulas A, Avci N, Kos T, Cubukcu E, Olmez
OF, Bulut N and Degirmenci M: Are neutrophil/lymphocyte ratio and
platelet/lymphocyte ratio associated with prognosis in patients
with HER2-positive early breast cancer receiving adjuvant
trastuzumab? J BUON. 20:714–722. 2015.PubMed/NCBI
|
|
21
|
Krenn-Pilko S, Langsenlehner U, Thurner
EM, Stojakovic T, Pichler M, Gerger A, Kapp KS and Langsenlehner T:
The elevated preoperative platelet-to-lymphocyte ratio predicts
poor prognosis in breast cancer patients. Br J Cancer.
110:2524–2530. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Seretis C, Seretis F, Lagoudianakis E,
Politou M, Gemenetzis G and Salemis NS: Enhancing the accuracy of
platelet to lymphocyte ratio after adjustment for large platelet
count: A pilot study in breast cancer patients. Int J Surg Oncol.
2012:6536082012.PubMed/NCBI
|
|
23
|
Gu M, Zhai Z, Huang L, Zheng W, Zhou Y,
Zhu R, Shen F and Yuan C: Pre-treatment mean platelet volume
associates with worse clinicopathologic features and prognosis of
patients with invasive breast cancer. Breast Cancer. Aug
26–2015.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
